Moody Aldrich Partners LLC Puma Biotechnology, Inc. Transaction History

Moody Aldrich Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$48.3 - $68.25 $381,521 - $539,106	-7,899 Closed	0 $0
Q1 2018 Apr 26, 2018	BUY	$59.7 - $99.25 $471,570 - $783,975	7,899 New	7,899 $538,000
Q4 2017 Jan 31, 2018	SELL	$93.85 - $132.45 $496,654 - $700,925	-5,292 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$72.0 - $119.75 $381,024 - $633,717	5,292	5,292 $634,000

102

29M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $138M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Aldrich Partners LLC with notifications on news.